Information about the AAN 2013 Annual Meeting

Article

News and updates about AAN 2013, the 65th Annual Meeting of the American Academy of Neurology.

American Academy of Neurology 65th Annual Meeting

March 16-23, 2013

San Diego, CA

The 2013 AAN annual meeting will be held in the San Diego Convention Center.

Described by the AAN as “the world's most important annual event for neurologists and neuroscience professionals,” the 2013 annual meeting will offer cutting-edge scientific presentations and comprehensive educational programs to more than 10,000 attendees from across the globe.

Planning your meeting

The AAN Annual Meeting app enables attendees to browse scientific abstracts, events, programs, and exhibitor listings; access general meeting information, FAQs, and interactive maps of the San Diego Convention Center; get real-time listings of ‘What’s on Now’ and the latest meeting news and alerts about program changes.

Download the complete listing of scientific abstracts to be presented at this year’s meeting.

You can also search the AAN annual meeting program by date, keyword, and presenter.

Key resources for this year’s meeting

The 2013 Emerging Science program schedule offers information on the 12 presentations and nine posters that are “new and of sufficient scientific importance to warrant expedited presentation and publication.”

Listing of plenary sessions and subspecialty focused program tracks at this year’s meeting.

Schedule of specialty events and networking opportunities.

Exhibit hall schedule and information

Exhibit hall hours:

  • Monday, March 18 (Opening Reception): 4:30- 6:30pm
  • Tuesday, March 19: 12:00 - 5:00pm
  • Wednesday, March 20: 12:00 - 5:00pm
  • Thursday, March 21: 11:00am - 3:00pm

Download a copy of the exhibit hall floor plan.

Related Videos
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA
Joel Gelfand, MD, MSCE: Phototherapy Utility in Psoriasis
Pediatric Hidradenitis Suppurativa Severity not Linked to Obesity
Rizankizumab and the KNOCKOUT Study, with Andrew Blauvelt, MD, MBA
© 2024 MJH Life Sciences

All rights reserved.